Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
04/11/2002 | WO2002028831A1 Inhibitors of prenyl-protein transferase |
04/11/2002 | WO2002028829A2 Peptide deformylase inhibitors |
04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
04/11/2002 | WO2001077079A3 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
04/11/2002 | WO2001019797A3 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
04/11/2002 | US20020042511 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
04/11/2002 | US20020042501 Antiproliferative and antitumor agents and angiogenesis inhibitors |
04/11/2002 | US20020042430 Novel esters of 1, 4-disubstituted piperidine derivatives |
04/11/2002 | US20020042398 Novel lactam metalloprotease inhibitors |
04/11/2002 | US20020042397 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
04/11/2002 | US20020042396 Amino acid derivatives |
04/11/2002 | US20020042377 Rotamase enzyme activity inhibitors |
04/11/2002 | CA2424870A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
04/10/2002 | EP1194427A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
04/10/2002 | EP1194426A2 Benzofurane derivatives |
04/10/2002 | EP1194418A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
04/10/2002 | EP1194417A1 Phenoxy fluoropyrimidines |
04/10/2002 | EP1194416A1 Halopyrimidines |
04/10/2002 | EP1194411A1 Benzoylpyridazines |
04/10/2002 | EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
04/10/2002 | EP1194144A1 Antibacterial compounds |
04/10/2002 | EP1112261B1 2-ethyl-2,3-dihydrobenzofuran-carboxylic acid ester derivative, preparation method and use for preparing efaroxan derivatives |
04/10/2002 | EP1087662B1 Composition for keeping away vermin |
04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
04/10/2002 | EP0797573B1 4-heteroaryl-1,2,4-triazole derivatives with herbicidal properties |
04/10/2002 | EP0734387B1 Hiv protease inhibitors |
04/10/2002 | CN1344266A Novel compounds |
04/10/2002 | CN1344265A Piperidine, tetrahydropyridine and piperazine derivatives, their prepn. and use |
04/10/2002 | CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents |
04/10/2002 | CN1344261A 2,4-diamino-1,3,5-triazines, method for producing them and their use as herbicides and plant growth regulators |
04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
04/09/2002 | USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
04/09/2002 | US6369100 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
04/09/2002 | US6369083 2-methoxyimino-2 (pyrinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring |
04/09/2002 | US6369077 Protease inhibitors |
04/09/2002 | US6369075 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B |
04/09/2002 | US6369068 Amino substituted pyrimidine containing compounds |
04/09/2002 | US6369057 Quinoxalines, processes for their preparation and their use |
04/09/2002 | CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
04/09/2002 | CA2171675C Aromatic heterocyclic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
04/09/2002 | CA2071224C Quinoline derivatives, their production and use |
04/09/2002 | CA2024185C Substituted 4,5-diamino-1,2,4-triazol-3-(thi)ones |
04/04/2002 | WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa |
04/04/2002 | WO2002026706A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
04/04/2002 | WO2002026228A1 Benzimidazolone antiviral agents |
04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
04/04/2002 | WO2002026220A2 Taxoid conjugates as antimitotic and antitumor agents |
04/04/2002 | WO2002026216A1 Pharmaceutical oxan preparation |
04/04/2002 | WO2001089451A3 Protease inhibitors |
04/04/2002 | WO2001081308A3 Aminopiperidines for use as glyt-1 inhibitors |
04/04/2002 | US20020040155 Radiosensitizing taxanes and their pharmaceutical preparations |
04/04/2002 | US20020040147 Novel catechols as antimicrobial agents |
04/04/2002 | US20020040146 Useful as inhibitors of metalloproteases, e.g. zinc proteases, and which are effective in therapy of disease states associated with vasoconstriction |
04/04/2002 | US20020040144 For therapy of thrombotic disease, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury |
04/04/2002 | US20020040048 (2S,4R)-4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid N'-isobutyl-N'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
04/04/2002 | US20020040038 Administering donepezil or its hydrochloride salt |
04/04/2002 | US20020040028 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
04/04/2002 | DE10044091A1 Chromanonderivate Chromanone |
04/04/2002 | CA2424949A1 Pharmaceutical oxan preparation |
04/04/2002 | CA2423483A1 Taxoid conjugates as antimitotic and antitumor agents |
04/04/2002 | CA2423434A1 Lactone integrin antagonists |
04/04/2002 | CA2422873A1 Piperazin-2-one amides as inhibitors of factor xa |
04/03/2002 | EP1193265A2 A process for the preparation of 4-[2-(aryl or heterocyclo)-1H-imidazol-1-yl]benzenesulfonamides |
04/03/2002 | EP1192152A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
04/03/2002 | EP1192151A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
04/03/2002 | EP1192148A1 Thiochroman derivatives resisting neurological disorders |
04/03/2002 | EP1192146A1 Chroman derivatives resisting neurological disorders |
04/03/2002 | EP1192135A2 Serine protease inhibitors |
04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
04/03/2002 | EP1192132A2 Serine protease inhibitors |
04/03/2002 | EP1162201A9 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1158980A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1156807A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1140087A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP0999838B1 Self-emulsifying formulation for lipophilic compounds |
04/03/2002 | EP0873331B1 Benzofuran carboxamides and sulphonamides |
04/03/2002 | EP0865440B1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
04/03/2002 | EP0859774B1 Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
04/03/2002 | CN1343207A Benzofuran-2-ones as colorants for organic materials |
04/03/2002 | CN1343201A Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
04/03/2002 | CN1082049C Sulfoaminomethyl acid radical compound |
04/02/2002 | US6365652 Trisaryl-1,3,5-triazine ultraviolet light absorbers |
04/02/2002 | US6365620 Trifluoromethylpyrrolcarboxamides |
04/02/2002 | US6365613 Fungicidal mixtures |
04/02/2002 | US6365600 For therapy of condition associated with smooth muscle cell proliferation in a warm-blooded animal which comprises administering imidazol-5-yl-methyl-2-quinolinone derivatives |
04/02/2002 | US6365599 For therapy of benign prostatic hyperplasia |
04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
04/02/2002 | US6365584 For prophylaxis and therapy of inflammatory and/or allergic diseases, lung fibrosis, fibrosing alveolitis and scarring, collagenoses such as lupus erythematodes and sclerodermia as well as arteriosclerosis, psoriasis and neoplasm |
04/02/2002 | US6365552 Substituted 3-phenylpyrazoles |
04/02/2002 | US6365068 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
04/02/2002 | CA2223574C Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein b (apo b) secretion |
04/02/2002 | CA2178130C Method of producing 2-naphthamide derivative, and compounds for producing 2-naphthamide derivative |
03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
03/28/2002 | WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |